Treatment outcomes
. | Younger than 56 y . | 56-65 y . | 66-75 y . | Older than 75 y . |
|---|---|---|---|---|
| No. patients | 368 | 246 | 274 | 80 |
| Response, no. (%) | ||||
| CR | 235 (64) | 113 (46) | 108 (39) | 26 (33) |
| Resistant disease | 99 (27) | 91 (37) | 101 (37) | 29 (36) |
| Median overall survival, no. (95% CI) | 18.8 (14.9-22.6) | 9.0 (8.1-10.2) | 6.9 (5.4-7.7) | 3.5 (1.4-6.1) |
| No. patients with CR | 235 | 113 | 108 | 26 |
| Median disease-free survival, no. (95% CI) | 21.6 (15.8-25.5) | 7.4 (6.5-8.8) | 8.3 (6.3-10.2) | 8.9 (5.8-10.8) |
. | Younger than 56 y . | 56-65 y . | 66-75 y . | Older than 75 y . |
|---|---|---|---|---|
| No. patients | 368 | 246 | 274 | 80 |
| Response, no. (%) | ||||
| CR | 235 (64) | 113 (46) | 108 (39) | 26 (33) |
| Resistant disease | 99 (27) | 91 (37) | 101 (37) | 29 (36) |
| Median overall survival, no. (95% CI) | 18.8 (14.9-22.6) | 9.0 (8.1-10.2) | 6.9 (5.4-7.7) | 3.5 (1.4-6.1) |
| No. patients with CR | 235 | 113 | 108 | 26 |
| Median disease-free survival, no. (95% CI) | 21.6 (15.8-25.5) | 7.4 (6.5-8.8) | 8.3 (6.3-10.2) | 8.9 (5.8-10.8) |
CI indicates confidence interval; CR, complete response.